Study to Assess the Efficacy and Safety of Repeated Administration of BIM 23A760 in Patients With Acromegaly
Status:
Terminated
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of repeated subcutaneous (under the skin)
injections at different doses of BIM 23A760 on growth hormone and insulin-like growth
factor-1 levels in patients with acromegaly after 6 months of treatment.